CircNFIX promotes progression of pituitary adenoma via CCNB1 by sponging miR-34a-5p

被引:19
|
作者
Cheng, Jianhua [1 ]
Nie, Ding [1 ]
Li, Bin [2 ]
Gui, SongBai [1 ]
Li, ChuZhong [2 ]
Zhang, YaZhuo [2 ]
Zhao, Peng [1 ]
机构
[1] Capital Med Univ, Neurosurg Dept, Beijing Tiantan Hosp, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China
[2] Beijing Neurosurg Inst, Dept Cell & Biol, Beijing 100070, Peoples R China
关键词
CircNFIX; MiR-34a-5p; CCNB1; Progression; Pituitary adenoma; CIRCULAR RNAS; CELL-CYCLE; PROLIFERATION; CANCER; ROLES; OVEREXPRESSION; GROWTH; GLIOMA;
D O I
10.1016/j.mce.2020.111140
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Previous studies have shown that CCNB1 affects the invasiveness of pituitary adenomas, and it is of great significance to find the upstream mechanism of regulating CCNB1. In this study, we explored a significantly overexpressed circRNA in invasive pituitary adenomas. Based on bioinformatics analysis and mechanism experiments, we determined that circNFIX (has-circ_0005660) affects cell invasion, migration and proliferation in pituitary adenomas by sponging miR-34a-5p through CCNB1. In pituitary adenoma tissues, the expression of circNFIX and CCNB1 was upregulated, while miR-34a-5p expression was downregulated. The silencing of circNFIX or overexpression of miR-34a-5p inhibited cell invasion, migration and proliferation. Inhibition of miR34a-5p expression reversed the inhibitory effect of circNFIX silencing on the progression of pituitary adenoma. In conclusion, CircNFIX affects cell invasion, migration, and proliferation in pituitary adenomas by sponging miR-34a-5p through CCNB1. Therefore, circNFIX is expected to serve as a potential target for the treatment of pituitary adenomas.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p
    Jiang, Xingkang
    Guo, Shanqi
    Zhang, Yangyi
    Zhao, Yang
    Li, Xiaojiang
    Jia, Yingjie
    Xu, Yong
    Ma, Baojie
    CELLULAR SIGNALLING, 2020, 65
  • [2] AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription
    Wen, Jiling
    Wang, Xuechun
    Yang, Guosheng
    Zheng, Junhua
    HELIYON, 2024, 10 (08)
  • [3] NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway
    Xu, Haiyang
    Zhang, Yu
    Qi, Ling
    Ding, Lijuan
    Jiang, Hong
    Yu, Hongquan
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [4] CircPVT1 promotes the tumorigenesis and metastasis of osteosarcoma via mediation of miR-26b-5p/CCNB1 axis
    Huang, Sheng-Xiang
    Mei, Hai-Bo
    Liu, Kun
    Tang, Jin
    Wu, Jiang-Yan
    Zhu, Guang-Hui
    Ye, Wei-Hua
    JOURNAL OF BONE AND MINERAL METABOLISM, 2022, 40 (04) : 581 - 593
  • [5] LncRNA BBOX1-AS1 promotes pituitary adenoma progression via sponging miR-361-3p/E2F1 axis
    Wu, Haijun
    Zhou, Shaolong
    Zheng, Yuqian
    Pan, Zheng
    Chen, Yongshun
    Wang, Xinjun
    ANTI-CANCER DRUGS, 2022, 33 (07) : 652 - 662
  • [6] circAGTPBP1 promotes the progression of papillary thyroid cancer through the notch pathway via the miR-34a-5p/notch1 axis
    Dai, Lei
    Zhang, Weidong
    Wang, Yinchun
    Yu, Kejie
    Le, Qi
    Wu, Xianjiang
    ISCIENCE, 2023, 26 (09)
  • [7] The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
    Youguang Pu
    Fangfang Zhao
    Yinpeng Li
    Mingda Cui
    Haiyan Wang
    Xianghui Meng
    Shanbao Cai
    BMC Cancer, 17
  • [8] The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
    Pu, Youguang
    Zhao, Fangfang
    Li, Yinpeng
    Cui, Mingda
    Wang, Haiyan
    Meng, Xianghui
    Cai, Shanbao
    BMC CANCER, 2017, 17
  • [9] MiR-34a-5p promotes hepatic gluconeogenesis by suppressing SIRT1 expression
    Wang, Yiru
    Zhou, Feiye
    Li, Mingzhu
    Zhang, Yumei
    Li, Na
    Shao, Li
    EXPERIMENTAL CELL RESEARCH, 2022, 420 (01)
  • [10] LncRNA MYMLR promotes pituitary adenoma development by upregulating carbonyl reductase 1 via sponging miR-197-3p
    Wang, Tuo
    Mao, Ping
    Zhang, Yan
    Cui, Bo
    Wang, Mao-De
    Li, Ya
    Gao, Ke
    ANTI-CANCER DRUGS, 2022, 33 (10) : 1058 - 1068